Terminated OBSERVATIONAL NCT01496794

Endophthalmitis Cultures (PROSPER)

Prospective Surveillance of Patients With Endophthalmitis for Multi-antibiotic Resistance (PROSPER) Study

Sponsor: Vanderbilt University

Updated 8 times since 2017 Last updated: Feb 20, 2017 Started: Oct 31, 2011 Primary completion: Apr 30, 2016 Completion: Apr 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

poor enrollment

A observational or N/A phase clinical study on Endophthalmitis, this trial is terminated or withdrawn. The trial is conducted by Vanderbilt University and has accumulated 8 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Study Description(click to expand)

Adult patients over 18 years of age presenting with endophthalmitis and able to sign consent.

Status Flow

Change History

8 versions recorded

Jan 2026 — Present [monthly]

Terminated
Sep 2024 — Present [monthly]

Terminated
Jul 2024 — Sep 2024 [monthly]

Terminated
Jan 2021 — Jul 2024 [monthly]

Terminated
Jun 2018 — Jan 2021 [monthly]

Terminated

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Terminated

Phase: NA → None
May 2017 — Apr 2018 [monthly]

Terminated NA

Status: Unknown Status → Terminated
Jan 2017 — May 2017 [monthly]

Unknown Status NA

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Vanderbilt University

Data source: Vanderbilt University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Nashville, United States